John Nilon

𝐀𝐭𝐭𝐞𝐧𝐭𝐢𝐨𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐂𝐄𝐎𝐬 𝐚𝐧𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐋𝐞𝐚𝐝𝐞𝐫𝐬: Check Out This Transformational VP of R&D Candidate (𝘗𝘳𝘦𝘴𝘦𝘯𝘵𝘭𝘺 𝘌𝘮𝘱𝘭𝘰𝘺𝘦𝘥 - 𝘕𝘰𝘵 𝘈𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘖𝘯 𝘛𝘩𝘦 𝘖𝘱𝘦𝘯 𝘔𝘢𝘳𝘬𝘦𝘵)! Our executive search firm is 𝐞𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞𝐥𝐲 representing a highly accomplished and mission-driven VP of Research & Development who has a stellar track record in leading R&D teams to develop FDA-approved products and drive market success. 𝐖𝐡𝐚𝐭 𝐓𝐡𝐢𝐬 𝐂𝐚𝐧𝐝𝐢𝐝𝐚𝐭𝐞 𝐁𝐫𝐢𝐧𝐠𝐬: - Proven Innovator: Spearheaded multi-disciplinary R&D teams to secure FDA approvals for groundbreaking therapies. - Patent Powerhouse: Holder of 20 US patents and co-author of 20 published papers. - Startup to Success: Successfully scaled both national and international R&D teams, transforming concepts into commercially viable products and expanding global market presence. 𝐈𝐝𝐞𝐚𝐥 𝐑𝐨𝐥𝐞𝐬: - Chief Scientific Officer (CSO) - Vice President of Research & Development (VP R&D) - Head of Regulatory Affairs - Director of Product Development 𝐖𝐡𝐲 𝐓𝐡𝐢𝐬 𝐂𝐚𝐧𝐝𝐢𝐝𝐚𝐭𝐞 𝐂𝐨𝐮𝐥𝐝 𝐃𝐫𝐢𝐯𝐞 𝐈𝐦𝐦𝐞𝐧𝐬𝐞 𝐈𝐦𝐩𝐚𝐜𝐭 𝐘𝐨𝐮𝐫 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧: - Significant Biotech Expertise: Mastery across chemistry, biophysics, pharmacology, materials science, and various engineering disciplines, ensuring a comprehensive approach to drug development. - Regulatory Savvy: Extensive experience with FDA interactions, having co-authored multiple IND filings and secured NDA approvals, ensuring regulatory compliance and streamlined approval processes. - Leadership Excellence: Demonstrated ability to build and mentor diverse, high-performing R&D teams, driving innovation and achieving strategic objectives in fast-paced environments. This candidate has shown significant employment tenure historically throughout their career and has impactful executives willing to speak on their behalf as professional references. They want to spend the last decade of their career contributing to one more company's mission that will positively impact people's lives. Due to life circumstances, this candidate is willing to relocate to many areas across the US if they find that ideal opportunity outside of California. Biotech Leaders - Your Next Innovator Awaits! If you’re ready to harness top-tier talent to drive your company’s growth and innovation, let’s connect! This innovative leader is ready to propel your biotech firm to new heights. 📩 Contact Me Today to learn more about how this VP of R&D can be the catalyst for your next breakthrough. #Biotech #Innovation #Leadership #RegulatoryAffairs #R&D #ExecutiveTalent #CareerOpportunities

1

🧬 Life Sciences Startup Leaders 🧬 This week has been incredible, building relationships with "off-market" mission-driven leaders in the biotech space. We've had the privilege to network with: - Sales and Business Development leaders - Seasoned Finance leaders - Regulatory leaders - Technical leaders - R&D executives - Medical Writers And that's just the beginning! As a boutique search firm dedicated to the life sciences space, our goal is to make ideal matches - and we believe we're only as good as our last placement! This is why we dedicate time to proactively network with prominent leaders in the industry to understand what drives them in their career, the state of affairs at their present firm, and micro/macro trends they're seeing in the industry. We proactively build our network on a daily basis with highly sought-after and respected leaders in the Life Sciences space. This allows us to be thoughtful and discerning about each candidate we present to our client partners. It's an amazing feeling to contribute toward the betterment of biotech firms who are positively impacting the world as we know it - while simultaneously helping these respected leaders improve their lives by finding the best possible career match based on their goals. As Dr. Leroy Hood said: "The biotech industry is where the most brilliant minds meet the most cutting edge science to create a future of unimaginable possibilities" Together, we're shaping the future of healthcare and innovation. Let's connect and collaborate to drive forward our shared vision for a brighter future ahead! #Biotech #Pharma #DTx

2

The push for biosimilars for historically expensive specialty treatments could redefine affordability in chronic disease management, not just through lower drug costs, but by fundamentally altering the cost-benefit equation for healthcare systems. This is playing a big role in incentivizing preventative strategies, ultimately leading to a more sustainable approach to managing chronic illnesses. #Biosimilars #Healthcare #PharmacyBenefits

17

Lots of things can go right for new #lifesciences CEOs, but they also must navigate the many challenges that come with the territory. Chief among those – loneliness, unearthing ‘blind spots’, and measuring success. Being a CEO is a taxing job and no amount of preparation can guarantee a smooth ride. Some great perspectives are featured in this article by Edward M. Kaye, MD, CEO of Stoke Therapeutics; Stan Wang, MD, PhD, CEO of Thymmune Therapeutics; and Nabiha Saklayen, co-founder and CEO of Cellino. #executivesearch

13

Prestige Scientific is excited to announce the completed search for a Fractional Chief Medical Officer with our partner, a well-funded biotech based in California focused on true precision immunology through data-guided target selection with multi-specific antibodies. This team of experienced drug developers has designed bispecific antibodies with “best” and “first”- in class potential for autoimmune/inflammatory diseases. Our client required interim leadership in refining and executing clinical development strategies for their pipeline. This involved ensuring strategic alignment with business goals and regulatory standards. Key responsibilities included reviewing clinical trial data, optimizing trial protocols, and providing critical insights to enhance decision-making processes. Effective communication of scientific findings to diverse stakeholders such as investors, partners, and regulatory bodies was also crucial. Prestige Scientific undertook a comprehensive search, identifying 7 highly qualified candidates for the role. Each candidate was assessed based on their extensive experience in translational sciences, clinical development, and therapeutic expertise relevant to autoimmune and inflammatory diseases. The selected candidate is a seasoned physician-scientist with over 20 years of industry experience. They bring a wealth of knowledge spanning all phases of drug development, particularly in the client’s specialized therapeutic area. Their expertise includes guiding clinical programs from inception through regulatory approval, making them a pivotal asset in advancing the company’s innovative pipeline. Additionally, their established network and credibility within the industry are instrumental in fostering strategic partnerships and securing investor confidence. #fractionalleadership #cmo #clinicaldevelopment #biotech #executivesearch #prestigescientific

6

The true success of any life sciences therapy is its ability to reach the patient, which medical publications can enhance with the right technology and measurement practices in place. As new technology becomes available, manufacturers must use it and enhanced data collection and communication methods to improve medical publications’ effectiveness and couple it with improved data collection and communication. When these practices are paired with human expertise, the ability to give patients and providers information they can use skyrockets, improving health outcomes and the product’s success. 

7